News
The consumables segment accounted for the largest share by product & service segment in the biomarkers market in 2023. By product & service, the biomarkers market is categorized into consumables, ...
Learn more about whether Moderna, Inc. or Vericel Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Based on indication, Global Nanomedicine Therapeutics Market is divided into Oncology, Infectious Disease, Cardiology, and Neurological Disease segments. The oncology segment holds the largest share, ...
Despite promising technology and FDA clearances, Pulse Biosciences lacks a revenue stream and remains in the testing phase with no commercialized products. The company has a market cap of $974mn ...
Michelle Xia represents a rising generation of biotech companies in China challenging Western giants.
Merck & Co has continued to bolster its pipeline with smaller deals – with its latest a $1.35 billion agreement to buy Imago BioSciences and its bomedemstat drug candidate for blood disorders.
Immunohistochemistry_Market_Overview_2025-2034 Digital pathology innovations and companion diagnostics drive 8% CAGR in market, with North ...
The life sciences company Solid Biosciences is merging with the privately ... Its key assets include product candidates for Duchenne muscular dystrophy (DMD), Friedreich’s ataxia, and BAG3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results